FDA Grants Breakthrough Therapy Designation to Nacuity’s NPI-001 Investigational Therapy for Retinitis Pigmentosa
Ophthalmology Times articles related to Retina Diseases: Retina October 3, 2025 Author Martin David Harp Key Takeaways NPI-001 targets oxidative stress, protecting retinal cells in […]